Traumatic Brain Injuries Assessment Market

Traumatic Brain Injuries Assessment Market Size

Traumatic Brain Injuries Assessment Market was valued at USD 2.9 billion in 2023 and is expected to exhibit growth at a CAGR of 7.4% from 2024 to 2032. High market growth can be attributed to the ongoing advancements in diagnostic technologies, increasing incidence of traumatic brain injuries, rising geriatric population, growing number of sports-related head injuries, and escalating healthcare expenditure, among other contributing factors.

Moreover, traumatic brain injuries (TBIs) are a major cause of morbidity and mortality worldwide, often resulting from accidents, falls, sports injuries, and violence. The high incidence of TBIs drives the demand for effective assessment tools to diagnose and manage these injuries promptly. For instance, the American Association of Neurological Surgeons (AANS) estimates that 1.7 to 3.8 million TBIs occur annually in the U.S., with sports and leisure activities accounting for 10% of these cases.

Furthermore, ongoing advancements in diagnostic technologies, such as neuroimaging (MRI, CT scans), biomarker identification, and portable diagnostic devices, have improved the accuracy, speed, and convenience of TBI assessments. These technological innovations enable healthcare professionals to diagnose TBIs more effectively, leading to better patient outcomes and driving market growth.

Traumatic brain injuries assessment refers to the process of evaluating and diagnosing brain injuries resulting from external forces such as a blow or jolt to the head. Assessment involves various methods including clinical evaluation, neuroimaging (like CT scans or MRI), and the use of biomarkers to determine the severity of the injury and guide treatment decisions.

Traumatic Brain Injuries Assessment Market Trends

The market is experiencing several notable trends that are shaping its growth and development. Factors such as continuous innovations in neuroimaging techniques, growing demand for point-of-care and portable medical devices, and surging need of integrated machine learning and artificial intelligence in healthcare, among other factors are propelling the industry growth.

• Further, the demand for personalized medicine is influencing the TBI assessment market. Personalized diagnostic approaches consider individual patient factors such as genetics, medical history, and specific injury characteristics to tailor assessment and treatment plans. Precision diagnostics aim to provide more accurate and individualized evaluations, improving patient outcomes.
  
• Moreover, development and adoption of portable and point-of-care diagnostic devices are growing. These devices enable rapid, on-site assessment of TBIs, which is particularly valuable in emergency settings, sports fields, and military environments. Technologies such as handheld ultrasound devices and portable EEG systems are becoming more prevalent, providing immediate diagnostic capabilities, thereby aforementioned factors are expected to drive the market.
  

Traumatic Brain Injuries Assessment Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on product, the market is categorized into screening devices and monitoring devices. The screening devices segment is bifurcated into computerized tomography (CT) scan, magnetic resonance imaging (MRI), and other screening devices. The monitoring devices segment is further bifurcated into intracranial pressure (ICP) monitoring and partial pressure of oxygen in brain tissue (pBrO2). The screening devices generated the highest revenue of USD 2.3 billion in 2023.

• Growing awareness of sports-related concussions and their potential long-term effects has driven the increased adoption of screening devices in sports. Sports organizations, schools, and professional teams are now utilizing these devices to monitor athletes for signs of brain injuries, enabling prompt intervention and reducing the risk of further harm.
  
• Moreover, advancements in technology have led to the development of more sophisticated and accurate screening devices for TBIs. Innovations such as portable neuroimaging tools, handheld devices, and advanced algorithms enhance the ability to detect and assess brain injuries more effectively, driving the market for these devices, thus leading to the segmental growth.
  

Learn more about the key segments shaping this market

Download Free PDF

Based on end-use, the traumatic brain injuries assessment market is segmented into hospitals, diagnostic centers, and other end-users. The hospitals segment dominated the market in 2023 and is anticipated to reach USD 3.2 billion by 2032.

• Hospitals are often the first point of care for individuals with TBIs, which frequently result from accidents, falls, sports injuries, and violence. The high incidence of TBIs necessitates the availability of advanced assessment tools and protocols in hospital settings to provide immediate and accurate diagnoses.
  
• Additionally, the increase in the number of hospitals enhances access to advanced diagnostic and treatment facilities for TBIs, ensuring timely and accurate assessment. This expansion supports the availability of specialized care and multidisciplinary teams, improving patient outcomes and driving market growth.
  

Looking for region specific data?

Download Free PDF

North America traumatic brain injuries assessment market accounted for USD 1.2 billion market revenue in 2023 and is anticipated to grow at CAGR of 6.8% between 2024 and 2032 period.

• North America boasts a well-developed healthcare infrastructure with access to advanced medical technologies and highly trained healthcare professionals. The availability of sophisticated medical facilities and the adoption of cutting-edge diagnostic tools support the growth of the TBI assessment market.
  
• Furthermore, the region is a hub for technological innovation in medical devices. Continuous advancements in neuroimaging, portable diagnostic devices, and biomarker-based diagnostics have improved the accuracy and efficiency of TBI assessments. The adoption of these advanced technologies drives market growth.
  

Germany traumatic brain injuries assessment market is projected to grow remarkably in the coming years.

• Germany has stringent occupational safety regulations to protect workers from injuries, including TBIs. The emphasis on workplace safety drives the demand for TBI assessment tools in industries with a high risk of head injuries, such as construction and manufacturing.
  
• Additionally, the country’s government and healthcare authorities are actively involved in initiatives aimed at improving TBI diagnosis and treatment. Research funding, grants, and public health policies support the development and adoption of advanced TBI assessment tools, contributing to market growth.
  

Japan holds a dominant position in the Asia Pacific traumatic brain injuries assessment market.

• Japan has one of the world’s fastest-aging populations. The elderly are more susceptible to falls and other accidents that can lead to TBIs. The growing number of older adults increases the demand for effective TBI assessment tools to diagnose and manage brain injuries in this demographic.
  
• Moreover, the country ’s advanced healthcare infrastructure supports the adoption of cutting-edge medical technologies. High standards of medical care and the availability of state-of-the-art equipment in hospitals and clinics contribute to the growth of the TBI assessment market.
  

Traumatic Brain Injuries Assessment Market Share

The market for traumatic brain injuries assessments is very competitive, with both established medical device companies and new startups driving progress. These companies invest a lot in research and development to improve the accuracy and efficiency of their diagnostic tools. Newer companies focus on creating innovative solutions that offer quick point-of-care testing. As the market grows, collaboration and ongoing innovation will be key to meeting the increasing demand for effective TBI assessment tools. This will help improve patient outcomes and reduce the long-term economic impact of traumatic brain injuries.

Traumatic Brain Injuries Assessment Market Companies

Prominent players operating in the Traumatic Brain Injuries Assessment industry include:

• Accuray Incorporated
• Asahi Kasei Corporation
• BrainScope, Inc.
• Compumedics Ltd.
• CurveBeam AI, Ltd.
• FUJIFILM Holdings Corporation
• GE Healthcare
• InfraScan, Inc.
• Koninklijke Philips N.V.
• Natus Medical, Inc.
• Neusoft Corporation
• Nihon Kohden Corporation
• Oculogica
• Raumedic AG
• Siemens Healthineers AG
  

Traumatic Brain Injuries Assessment Industry News:

• In February 2024, Philips and Synthetic MR introduced Smart Quant Neuro 3D, an advanced tool aimed at improving objective decision support in diagnosing and treating brain disorders like multiple sclerosis (MS), traumatic brain injury (TBI), and dementia. This collaboration signifies a significant advancement in neuroimaging technology, promising to enhance diagnostic precision and treatment effectiveness for patients with complex neurological conditions.
  
• In March 2022, Oculogica announced the launch of the new EyeBOX device, lightweight, battery-operated, and small enough to fit in a backpack, making it easy to use in both clinical and sports settings. This advancement benefited the company by enhancing the portability and usability of its product, thereby broadening its market reach and increasing its appeal to a wider range of healthcare providers and sports organizations.
  

The traumatic brain injuries assessment market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 - 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Screening devices
  • Computerized tomography (CT) scan
  • Magnetic resonance imaging (MRI)
  • Other screening devices
• Monitoring devices
  • Intracranial pressure (ICP) monitoring
  • Partial pressure of oxygen in brain tissue (pBrO2)

Market, By End-use

• Hospitals
• Diagnostic centers
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa